Chicago, May 16, 2016 – The American Brain Tumor Association (ABTA) will offer a free interactive “journey through the brain” experience with a larger-than-life inflatable brain exhibit at the BT5K Los Angeles Breakthrough for Brain Tumors Run & Walk on Saturday, May 21 at the Pomona Fairplex. For more information or to register, visit www.bt5k.org
The following is a statement by Elizabeth M. Wilson, president and CEO, American Brain Tumor Association, on the decision by Celldex Therapeutics Inc. to discontinue a late-stage study of its brain cancer vaccine RINTEGA®.
The American Brain Tumor Association (ABTA) has announced an expanded patient-education meeting program in an effort to bring the most up-to-date brain tumor information to more patients and families in their local communities. The ABTA’s Partners in Treatment and Care meetings will be offered in three additional cities, for a total of five cities, beginning in March 2016.